Medicinal Products

Reblozyl

Name Reblozyl
Active Substance luspatercept
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code B03XA06

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/reblozyl

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back